Bush Signs Bill Providing FDA $1.73 Billion for Fiscal 2008
On December 26, 2007, President Bush signed into law H.R. 2764, which gives the FDA nearly $1.73 billion in funding for fiscal 2008.
On December 26, 2007, President Bush signed into law H.R. 2764, which gives the FDA nearly $1.73 billion in funding for fiscal 2008.
As reported by FDA News, the bill gives the FDA more than $79 million above the president’s budget request and $145 million above the fiscal 2007 funding level. The Center for Drug Evaluation and Research (CDER) will receive more than $682 million, with $41.9 million of that going to the Office of Generic Drugs. The Center for Biologics Evaluation and Research (CBER) will receive more than $236 million.
Details on the bill can be seen at thomas.loc.gov/cgi-bin/bdquery/z?d110:h.r.02764,
FDANews report
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
